• Home
  • Stocks
  • Indraprastha Medical Corporation Ltd.

Indraprastha Medical Corporation Ltd.
Snapshot View

View in App

Prices View details >>

78.90 +0.35 ▲0.5%

22 March 2023, 09:07:20 AM
Volume: 0

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.apollohospdelhi.com
Market Cap 720.64 Cr.
Enterprise Value(EV) 515.82 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 8.89 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 8.84 Trailing Twelve Months Ending 2022-12
Industry PE 46.11 Trailing Twelve Months Ending 2022-12
Book Value / Share 39.75 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.98 Calculated using Price: 78.61
Dividend Yield 3.18 Period Ending 2022-03
No. of Shares Subscribed 9.17 Cr. 91,673,000 Shares
FaceValue 10
Company Profile
It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the company's diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.45%
1 Week
-1.00%
1 Month
-2.89%
3 Month
-3.31%
6 Month
+17.24%
1 Year
+26.85%
2 Year
+41.14%
5 Year
+63.69%
10 Year
+139.09%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 19.79 17.02 11.68 11.55 9.11 11.93 17.05 0.86 19.60
Return on Capital Employed (%) 25.78 23.29 17.72 16.98 14.40 18.29 20.15 2.80 27.58
Return on Assets (%) 7.99 7.30 5.42 5.71 4.74 6.65 10.01 0.53 13.12

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 187 195 224 231 232 244 268 273 325 344
Non Curr. Liab. 70 53 46 42 62 54 42 43 43 39
Curr. Liab. 192 194 191 186 138 124 140 116 94 198
Minority Int.
Equity & Liab. 449 442 461 458 432 422 449 432 462 580
Non Curr. Assets 302 293 308 301 299 287 308 291 304 279
Curr. Assets 147 149 152 158 133 136 141 141 157 301
Misc. Exp. not W/O
Total Assets 449 442 461 458 432 422 449 432 462 580

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 678 714 755 766 753 788 831 613 888 1,041
Other Income 1 1 2 0 1 0 1 1 3 6
Total Income 679 715 758 766 753 789 831 614 891 1,047
Total Expenditure -587 -630 -676 -687 -680 -707 -744 -573 -774 -895
PBIDT 92 86 82 79 74 81 87 41 117 152
Interest -10 -8 -7 -8 -9 -7 -6 -3 -3 -4
Depreciation -28 -28 -35 -31 -31 -30 -33 -33 -35 -38
Taxation -19 -17 -14 -15 -13 -16 -5 -2 -20 -28
Exceptional Items
PAT 35 32 24 26 21 28 44 2 59 82
Adjusted EPS 4 4 3 3 2 3 5 0 6 9

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 67 58 64 62 28 48 75 86 27 71
Cash Fr. Inv. -54 -22 -29 -33 -22 -30 -17 -40 -19 -51
Cash Fr. Finan. -13 -36 -35 -30 -5 -17 -44 -43 -3 -3
Net Change 0 0 0 0 0 1 14 4 5 17
Cash & Cash Eqvt 2 2 2 2 2 3 17 20 25 42

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.00 51.00 51.00 51.00 51.00 51.00 51.00 51.00 51.00
Public 49.00 49.00 49.00 49.00 49.00 49.00 49.00 49.00 49.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 21 Mar 2023
Loss of Share Certificates
Indraprastha Medical Corporation Limited has informed the Exchange about Loss of Share Certificates
Tue, 14 Feb 2023
Loss of Share Certificates
Indraprastha Medical Corporation Limited has informed the Exchange about Loss of Share Certificates
Mon, 13 Feb 2023
Loss of Share Certificates
Indraprastha Medical Corporation Limited has informed the Exchange about Loss of Share Certificates

Technical Scans View Details >>

Tue, 21 Mar 2023
Close Below Last Week Low Close Below Last Week Low
High Decrease in 1 Month High Decrease in 1 Month
CCI Oversold Zone CCI Oversold Zone
Mon, 20 Mar 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 229,424.41 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. 73,593.21 4,429.35 +0.2%
Divi's Laboratories Ltd. 73,553.38 2,770.90 +0.1%
Cipla Ltd. 69,632.88 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. 61,491.67 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. 51,277.87 1,517.85 +0.2%
Zydus Lifesciences Ltd. 48,378.30 479.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.47 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.20 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 30.72 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-12 26.39 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.34 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.82 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.47 479.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.15 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.34 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-12 5.92 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-12 3.07 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.80 479.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 0.04 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 957.00 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,429.35 +0.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,770.90 +0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 864.00 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,275.05 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.85 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.00 +0.1%

FAQ's On Indraprastha Medical Corporation Ltd.

What is Indraprastha Medical share price?
Can I buy Indraprastha Medical shares now?
What is the Dividend Yield of Indraprastha Medical?
What is the Market Cap of Indraprastha Medical?
What are the key metrics to analyse Indraprastha Medical?
What is the trend of Indraprastha Medical share price?